Suppr超能文献

原发性甲状腺功能减退患者服用氯贝丁酯所致的肌病

Clofibrate-induced myopathy in a patient with primary hypothyroidism.

作者信息

Hattori N, Shimatsu A, Murabe H, Nishimura M, Nakamura H, Imura H

机构信息

Department of Endocrinology, Kobe General Hospital, Japan.

出版信息

Jpn J Med. 1990 Sep-Oct;29(5):545-7. doi: 10.2169/internalmedicine1962.29.545.

Abstract

Acute muscle pain with stiffness developed in a patient with latent hypothyroidism after administration of clofibrate. Serum creatine kinase (CK), aspartate aminotransferase, and lactate dehydrogenase were markedly elevated, but returned to normal one and a half months after the discontinuation of clofibrate. Clofibrate challenge (750 mg/day) for three days caused muscle pain and an elevation in serum CK. Hypothyroidism may be a predisposing factor in the development of clofibrate-induced myopathy.

摘要

一名患有潜在甲状腺功能减退症的患者在服用氯贝丁酯后出现了伴有肌肉僵硬的急性肌肉疼痛。血清肌酸激酶(CK)、天冬氨酸氨基转移酶和乳酸脱氢酶显著升高,但在停用氯贝丁酯一个半月后恢复正常。连续三天进行氯贝丁酯激发试验(750毫克/天)导致肌肉疼痛和血清CK升高。甲状腺功能减退症可能是氯贝丁酯诱发肌病发生的一个易感因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验